SEC Form 4 · accession 0001209191-18-033629
NEUROCRINE BIOSCIENCES INC · NBIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Corinne H Nevinny
Director
Period of report
May 24, 2018
Accepted (ET)
May 25, 2018 · 7:56 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000914475
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock OptionF1 | $94.64 | May 24, 2018 | A | 12,500 | A | Jun 24, 2018 | May 24, 2028 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1Option vests in 12 equal monthly installments beginning June 24, 2018.